NA

Naman Agarwal

Active Director Whole-Time Director DIN 07379508
DIN 07379508 First appointment May 2016 Primary industry Manufacturing
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 4 historical roles
Total affiliations 6 Since May 2016
Shareholding value •••• Premium profile

About Naman Agarwal

Data last updated:

Naman Agarwal is a Whole-Time Director at Cleena Industries Private Limited (since 2016) and Director at Apollo Polyvinyl Private Limited (since 2024). The companies operate in Manufacturing, Plastics and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹116 Cr; the largest is Cleena Industries Private Limited at ₹116 Cr (FY 2025). Earlier, Naman Agarwal was a Director at Humanix Lifesciences Private Limited (2016–2024) and Designated Partner at Blufit Medicare Llp (from 2019) and 2 more.

DIN 07379508
Primary Designation Whole-Time Director
Industry Manufacturing
First Appointment 16 May 2016
Oldest Company Age 15 yrs
Largest company Cleena Industries Private Limited · ₹116 Cr (FY 2025)
Combined revenue ₹116 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cleena Industries Private Limited U74900UT2016PTC018040
Whole-Time Director16 May 20162016₹116 Cr (FY 2025)Active
Apollo Polyvinyl Private Limited U74990TN2011PTC080650
Director21 Nov 20242011₹4.9 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Humanix Lifesciences Private Limited U24303DL2016PTC300216
Director23 May 20162016₹1.40 Cr (FY 2025)Active
Designated Partner05 Jul 20192019Strike Off
Designated Partner14 Nov 20182018Strike Off
Designated Partner06 Dec 20182018Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Blufit Medicare Llp
Cleena Industries Private Limited
Cleena Polypack Llp
Potent Lifesciences Llp
Premium access

Shareholding and investment profile for Naman Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naman Agarwal

Naman Agarwal currently holds 2 directorships: Cleena Industries Private Limited (Whole-Time Director, since 16 May 2016, revenue ₹116 Cr (FY 2025)); Apollo Polyvinyl Private Limited (Director, since 21 Nov 2024, revenue ₹4.9 Lakh (FY 2025)).

Naman Agarwal was first appointed on 16 May 2016 as Whole-Time Director at Cleena Industries Private Limited. The most recent appointment on record is 21 Nov 2024 at Apollo Polyvinyl Private Limited.

The 2 current companies of Naman Agarwal that report revenue have a combined latest revenue of ₹116 Cr: Cleena Industries Private Limited ₹116 Cr (FY 2025); Apollo Polyvinyl Private Limited ₹4.9 Lakh (FY 2025).

Naman Agarwal held 4 earlier board appointments: Humanix Lifesciences Private Limited (Director, 23 May 2016 to 28 Mar 2024); Blufit Medicare Llp (Designated Partner, from 05 Jul 2019); Cleena Polypack Llp (Designated Partner, from 14 Nov 2018); Potent Lifesciences Llp (Designated Partner, from 06 Dec 2018).

The current boards of Naman Agarwal's companies include Alka Gupta (Cleena Industries Private Limited), Anugrah Gupta (Cleena Industries Private Limited), Pankaj Mittal (Cleena Industries Private Limited), Parveen Kumar (Cleena Industries Private Limited), Shivani Mittal (Cleena Industries Private Limited), Sharad Gupta (Apollo Polyvinyl Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available